Paper17617618
Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury.
Reutershan J and 4 others. J Immunol, 2007. Cited by 107 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. Papers, record 17617618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17617618
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemotaxis, Leukocyte | Major topic |
| Lipopolysaccharides | Major topic |
| Lung Diseases | Major topic |
| Receptor, Adenosine A2A | Major topic |
| Animals | |
| Capillary Permeability | |
| Chemokines | |
| Enzyme-Linked Immunosorbent Assay | |
| Flow Cytometry | |
| Immunohistochemistry | |
| Lung | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Neutrophils | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Transplantation Chimera |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 GM007267 | NIGMS NIH HHS | United States | T32GM007267 | PubMed and NIH | NIH RePORTER |
| HL73361 | NHLBI NIH HHS | United States | P01HL073361 | PubMed and NIH | NIH RePORTER |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 107 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,872,847 | CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39872847 | PubMed |
| 39,662,078 | Does Adenosine Triphosphate via Purinergic Receptor Signalling Fuel Pulmonary Fibrosis? | J Innate Immun | 2025 | https://conductscience.org/library/papers/39662078 | PubMed |
| 38,312,838 | Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome. | Front Immunol | 2024 | https://conductscience.org/library/papers/38312838 | PubMed |
| 37,664,715 | Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist. | Heliyon | 2023 | https://conductscience.org/library/papers/37664715 | PubMed |
| 36,002,086 | Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI. | J Ethnopharmacol | 2022 | https://conductscience.org/library/papers/36002086 | PubMed |
| 34,456,928 | DAMPening COVID-19 Severity by Attenuating Danger Signals. | Front Immunol | 2021 | https://conductscience.org/library/papers/34456928 | PubMed |
| 33,574,762 | Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33574762 | PubMed |
| 33,567,540 | Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33567540 | PubMed |
| 33,519,814 | Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury. | Front Immunol | 2020 | https://conductscience.org/library/papers/33519814 | PubMed |
| 33,336,290 | Comparison of direct and indirect models of early induced acute lung injury. | Intensive Care Med Exp | 2020 | https://conductscience.org/library/papers/33336290 | PubMed |
| 32,967,358 | Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? | J Clin Med | 2020 | https://conductscience.org/library/papers/32967358 | PubMed |
| 32,410,853 | Systemic Administration of Calea pinnatifida Inhibits Inflammation Induced by Carrageenan in a Murine Model of Pulmonary Neutrophilia. | Mediators Inflamm | 2020 | https://conductscience.org/library/papers/32410853 | PubMed |
| 32,210,974 | Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation. | Front Immunol | 2020 | https://conductscience.org/library/papers/32210974 | PubMed |
| 30,093,975 | Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI). | Oncotarget | 2018 | https://conductscience.org/library/papers/30093975 | PubMed |
| 29,545,806 | Purinergic Regulation of Neutrophil Function. | Front Immunol | 2018 | https://conductscience.org/library/papers/29545806 | PubMed |
| 29,326,725 | Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A2A- and A2B-Receptor Signaling in Acute Pulmonary Inflammation. | Front Immunol | 2017 | https://conductscience.org/library/papers/29326725 | PubMed |
| 28,798,196 | The hypoxia-adenosine link during inflammation. | J Appl Physiol (1985) | 2017 | https://conductscience.org/library/papers/28798196 | PubMed |
| 27,696,085 | Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium. | Purinergic Signal | 2017 | https://conductscience.org/library/papers/27696085 | PubMed |
| 27,347,328 | Pentoxifylline inhibits pulmonary inflammation induced by infrarenal aorticcross-clamping dependent of adenosine receptor A2A. | Am J Transl Res | 2016 | https://conductscience.org/library/papers/27347328 | PubMed |
| 27,016,586 | Adenosine influences myeloid cells to inhibit aeroallergen sensitization. | Am J Physiol Lung Cell Mol Physiol | 2016 | https://conductscience.org/library/papers/27016586 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADORA2A | 135 | PubTator's text mining | https://conductscience.org/library/genes/135 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17617618
GET https://conductscience.org/api/papers/v1/17617618/cited_by?page=2